A Generalized Lichen Planus Following COVID-19 Vaccination: A Case Report
Ann Dermatol. 2023 Nov;35(Suppl 2):S260-S264. doi: 10.5021/ad.22.026.ABSTRACTAs part of the efforts to overcome the ongoing coronavirus disease 2019 (COVID-19) pandemic, mass vaccination programs against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been initiated. Since then, an increasing number of cutaneous adverse events associated with the COVID-19 vaccines have been reported. Lichen planus (LP) is a rare inflammatory mucocutaneous disease with various clinical presentations, although uncommon, occurring following vaccination. There have been several cases of LP reported following COVID-19 vacc...
Source: Annals of Dermatology - December 7, 2023 Category: Dermatology Authors: Jee Yun Doh Ji Hyun Lee Source Type: research
A Case of Linear Hypertrophic Lichen Planus in a Pediatric Patient
Ann Dermatol. 2023 Nov;35(Suppl 2):S256-S259. doi: 10.5021/ad.21.300.ABSTRACTLichen planus (LP) is a chronic inflammatory disease of the skin and mucosa. Of the various types, the hypertrophic type is characterized by thickened, purplish hyperkeratotic plaques and nodules. The course of hypertrophic LP tends to be more chronic than those of other types. A 12-year-old girl presented with a 2-year history of warty papules and plaques in a zosteriform configuration along one flank. Histopathology revealed hyperkeratosis and papillomatosis with wedge-shaped hypergranulosis. A lichenoid lymphocytic infiltrate with vacuolar chan...
Source: Annals of Dermatology - December 7, 2023 Category: Dermatology Authors: Jin Ju Lee Rosa Kim Min Young Lee Ji Yeon Byun You Won Choi Hae Young Choi Source Type: research
A Generalized Lichen Planus Following COVID-19 Vaccination: A Case Report
Ann Dermatol. 2023 Nov;35(Suppl 2):S260-S264. doi: 10.5021/ad.22.026.ABSTRACTAs part of the efforts to overcome the ongoing coronavirus disease 2019 (COVID-19) pandemic, mass vaccination programs against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been initiated. Since then, an increasing number of cutaneous adverse events associated with the COVID-19 vaccines have been reported. Lichen planus (LP) is a rare inflammatory mucocutaneous disease with various clinical presentations, although uncommon, occurring following vaccination. There have been several cases of LP reported following COVID-19 vacc...
Source: Annals of Dermatology - December 7, 2023 Category: Dermatology Authors: Jee Yun Doh Ji Hyun Lee Source Type: research
A Case of Linear Hypertrophic Lichen Planus in a Pediatric Patient
Ann Dermatol. 2023 Nov;35(Suppl 2):S256-S259. doi: 10.5021/ad.21.300.ABSTRACTLichen planus (LP) is a chronic inflammatory disease of the skin and mucosa. Of the various types, the hypertrophic type is characterized by thickened, purplish hyperkeratotic plaques and nodules. The course of hypertrophic LP tends to be more chronic than those of other types. A 12-year-old girl presented with a 2-year history of warty papules and plaques in a zosteriform configuration along one flank. Histopathology revealed hyperkeratosis and papillomatosis with wedge-shaped hypergranulosis. A lichenoid lymphocytic infiltrate with vacuolar chan...
Source: Annals of Dermatology - December 7, 2023 Category: Dermatology Authors: Jin Ju Lee Rosa Kim Min Young Lee Ji Yeon Byun You Won Choi Hae Young Choi Source Type: research
A Generalized Lichen Planus Following COVID-19 Vaccination: A Case Report
Ann Dermatol. 2023 Nov;35(Suppl 2):S260-S264. doi: 10.5021/ad.22.026.ABSTRACTAs part of the efforts to overcome the ongoing coronavirus disease 2019 (COVID-19) pandemic, mass vaccination programs against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been initiated. Since then, an increasing number of cutaneous adverse events associated with the COVID-19 vaccines have been reported. Lichen planus (LP) is a rare inflammatory mucocutaneous disease with various clinical presentations, although uncommon, occurring following vaccination. There have been several cases of LP reported following COVID-19 vacc...
Source: Annals of Dermatology - December 7, 2023 Category: Dermatology Authors: Jee Yun Doh Ji Hyun Lee Source Type: research
A Case of Linear Hypertrophic Lichen Planus in a Pediatric Patient
Ann Dermatol. 2023 Nov;35(Suppl 2):S256-S259. doi: 10.5021/ad.21.300.ABSTRACTLichen planus (LP) is a chronic inflammatory disease of the skin and mucosa. Of the various types, the hypertrophic type is characterized by thickened, purplish hyperkeratotic plaques and nodules. The course of hypertrophic LP tends to be more chronic than those of other types. A 12-year-old girl presented with a 2-year history of warty papules and plaques in a zosteriform configuration along one flank. Histopathology revealed hyperkeratosis and papillomatosis with wedge-shaped hypergranulosis. A lichenoid lymphocytic infiltrate with vacuolar chan...
Source: Annals of Dermatology - December 7, 2023 Category: Dermatology Authors: Jin Ju Lee Rosa Kim Min Young Lee Ji Yeon Byun You Won Choi Hae Young Choi Source Type: research
A Generalized Lichen Planus Following COVID-19 Vaccination: A Case Report
Ann Dermatol. 2023 Nov;35(Suppl 2):S260-S264. doi: 10.5021/ad.22.026.ABSTRACTAs part of the efforts to overcome the ongoing coronavirus disease 2019 (COVID-19) pandemic, mass vaccination programs against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been initiated. Since then, an increasing number of cutaneous adverse events associated with the COVID-19 vaccines have been reported. Lichen planus (LP) is a rare inflammatory mucocutaneous disease with various clinical presentations, although uncommon, occurring following vaccination. There have been several cases of LP reported following COVID-19 vacc...
Source: Annals of Dermatology - December 7, 2023 Category: Dermatology Authors: Jee Yun Doh Ji Hyun Lee Source Type: research
Acitretin Plus Triamcinolone vs Triamcinolone Monotherapy for Symptomatic Oral Lichen Planus
This randomized clinical trial evaluates the efficacy and safety of oral acitretin plus topical triamcinolone acetonide, 0.1%, compared with triamcinolone acetonide monotherapy in patients with symptomatic oral lichen planus. (Source: JAMA Dermatology)
Source: JAMA Dermatology - December 6, 2023 Category: Dermatology Source Type: research
Senescence-associated secretory phenotypes in mesenchymal cells contribute to cytotoxic immune response in oral lichen planus
Oral lichen planus is a chronic inflammatory condition that adversely affects the oral mucosa; however, its etiology remains elusive. Consequently, therapeutic interventions for oral lichen planus are limited ... (Source: Immunity and Aging)
Source: Immunity and Aging - December 5, 2023 Category: Geriatrics Authors: Shogo Ijima, Yuki Saito, Sena Yamamoto, Kentaro Nagaoka, Taiki Iwamoto, Arisa Kita, Maki Miyajima, Tsukasa Sato, Akihiro Miyazaki and Takako S. Chikenji Tags: Research Source Type: research
Photodynamic therapy for refractory erosive oral lichen planus: a case series study
Oral lichen planus is a chronic inflammatory disease that occurs on the oral mucosa and is an oral potentially malignant disease. Treatment of oral lichen planus aims to promote healing of the erosion, relieve pain, reduce recurrence of the erosion and prevent canceration. Corticosteroids are the first line of treatment for oral lichen planus. Refractory oral lichen planus is a clinical classification of oral lichen planus that has not responded to corticosteroid treatment for more than two months. (Source: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics)
Source: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics - December 4, 2023 Category: ENT & OMF Authors: Jieyu Ming, Zhixin Yang, Tianqing Wang, Jiongke Wang, Xin Zeng Source Type: research
Nail lichen planus treatment safety
Expert Opin Drug Saf. 2023 Nov 28. doi: 10.1080/14740338.2023.2288902. Online ahead of print.ABSTRACTTopical therapies for nail lichen planus (clobetasol propionate, topical tacrolimus, bath-PUVA), intralesional treatment (triamcinolone), and systemic treatment (corticosteroids, retinoids, small molecule inhibitors (jak/stat inhibitors), TNF-alpha inhibitors (etanercept), systemic immunomodulators (oral calcineurin inhibitors, mycophenolate mophetil), and antimalarials (chloroquine), each with unique safety profiles and considerations. Herein, we discuss common and uncommon adverse events, as well as utilization for specia...
Source: Expert Opinion on Drug Safety - November 28, 2023 Category: Drugs & Pharmacology Authors: Eden N Axler Shari R Lipner Source Type: research
Nail lichen planus treatment safety
Expert Opin Drug Saf. 2023 Nov 28:1-12. doi: 10.1080/14740338.2023.2288902. Online ahead of print.ABSTRACTTopical therapies for nail lichen planus (clobetasol propionate, topical tacrolimus, bath-PUVA), intralesional treatment (triamcinolone), and systemic treatment (corticosteroids, retinoids, small molecule inhibitors (jak/stat inhibitors)), TNF-alpha inhibitors (etanercept), systemic immunomodulators (oral calcineurin inhibitors, mycophenolate mophetil), and antimalarials (chloroquine), each with unique safety profiles and considerations. Herein, we discuss common and uncommon adverse events, as well as utilization for ...
Source: Expert Opinion on Drug Safety - November 28, 2023 Category: Drugs & Pharmacology Authors: Eden N Axler Shari R Lipner Source Type: research
